Blog Mission at Work: Mike Hession Feb 15, 2013 Inspiring stories profiling how Charles River employees and their families are benefiting from our work. Immunometabolism: The Crossroads between Diabetes and Inflammation Jan 08, 2013 Two of the most fundamental requirements to our survival are the ability to survive periods of starvation and the capacity to mount an effective response against pathogenic invaders. NORD Explores the Economic Costs of Rare Disorders Dec 17, 2012 Together, there are nearly 7,000 orphan diseases that impact nearly 30 million Americans who NORD supports through education, research, and advocacy. Orphan Disease Market: Untapped Drug Development Opportunities Abound Dec 10, 2012 Orphan diseases used to be a lonely place in drug development. But with recent analyses showing high profitability potential, support from advocacy organizations, and new therapeutic approaches, companies are beginning to embrace rare diseases. Mission at Work: Linda Abrams May 31, 2012 Inspiring stories profiling how Charles River employees and their families are benefiting from our work. Mission at Work: Tim Wiley Apr 30, 2012 Inspiring stories profiling how Charles River employees and their families are benefiting from our work.
Mission at Work: Mike Hession Feb 15, 2013 Inspiring stories profiling how Charles River employees and their families are benefiting from our work.
Immunometabolism: The Crossroads between Diabetes and Inflammation Jan 08, 2013 Two of the most fundamental requirements to our survival are the ability to survive periods of starvation and the capacity to mount an effective response against pathogenic invaders.
NORD Explores the Economic Costs of Rare Disorders Dec 17, 2012 Together, there are nearly 7,000 orphan diseases that impact nearly 30 million Americans who NORD supports through education, research, and advocacy.
Orphan Disease Market: Untapped Drug Development Opportunities Abound Dec 10, 2012 Orphan diseases used to be a lonely place in drug development. But with recent analyses showing high profitability potential, support from advocacy organizations, and new therapeutic approaches, companies are beginning to embrace rare diseases.
Mission at Work: Linda Abrams May 31, 2012 Inspiring stories profiling how Charles River employees and their families are benefiting from our work.
Mission at Work: Tim Wiley Apr 30, 2012 Inspiring stories profiling how Charles River employees and their families are benefiting from our work.
